$7,284.58 average · fixed 12-month divisor
ORB + OF381 closed tradesNQ / MNQ sizingNo source · no number
FM300Results
See the profit.Measure the risk.
Near-year available-data NQ stress test · aggregate windows below · historical simulation
Current 30-day verification
Unavailable means
no current claim.
No completed-session boundary is currently published. ORB rolling evidence is unavailable: 0/30 days verified. OF rolling evidence is unavailable: 0/30 days verified. No current model result is shown unless every configured production route proves the complete window. These are unavailable, not zero, while official-calendar lineage and complete route evidence are verified. The archive below is a dated retrospective historical simulation, not customer performance or a guarantee.
Near-year available-data stress test · ORB + OF · one NQ
Profitable overall.
Not $5K prop-safe.
The merged sequence finished positive, but the account path crossed a $5,000 closed-loss boundary. Risk is shown beside return so the ending profit cannot hide the failure point.
0 overlapping positions · one contract reused
-1,079 ticks after the closing trade
Observed Sep 18, 2025 · starting-level baseline
Nov 25, 2025 peak → Feb 2, 2026 trough
Closed-trade sizing candidate · not a prop-survival finding
30 / 60 / 90-day historical research
Aggregate results.
Boundary intact.
Aggregate research console
2026-06-18 through 2026-07-17 · America/Los_Angeles
22 observed trade dates contribute to these aggregates. Day-level outcomes are not public.
Opening Range Breakout
- Net ticks
- +1,966
- Profit factor
- 1.80
- W-L-BE
- 9-6-0
- Closed DD
- 848 ticks
- Net ticks
- +310
- Profit factor
- 1.58
- W-L-BE
- 8-5-0
- Closed DD
- 203 ticks
Source-backed rolling window
Thirty days, fail-closed.
Checking the source-backed 30-day feed…
Dated 30-day historical simulation
Archived research.
Not current performance.
30 Pacific calendar days. Five released routes.
| Model | W-L-BE | Win rate | Net ticks | One mini eq. | Profit factor | Closed DD |
|---|---|---|---|---|---|---|
| FM300 ORB MNQ -> NQ14-day signal trial / Blue Pill / Red Pill | 9-6-0 | 60% | +1,966 | +$9,830 | 1.8 | 848 ticks $4,240 |
| FM300 ORB M2K -> RTY14-day signal trial / Blue Pill / Red Pill | 8-5-0 | 61.5% | +310 | +$1,550 | 1.58 | 203 ticks $1,015 |
| FM300 OF MNQ -> NQ14-day signal trial / Blue Pill / Red Pill | 13-4-0 | 76.5% | +4,457 | +$22,285 | 7.49 | 338 ticks $1,690 |
| FM300 OF MGC -> GC14-day signal trial / Blue Pill / Red Pill | 8-4-0 | 66.7% | +1,786 | +$17,860 | 2.95 | 310 ticks $3,100 |
| FM300 OF MYM -> YM14-day signal trial / Blue Pill / Red Pill | 9-2-0 | 81.8% | +1,077 | +$5,385 | 4.83 | 219 ticks $1,095 |
Calendar foundation
Official sessions.
Licensing-gated.
Official-calendar migration in progress
Current strategy scope
Five released routes.
Research stays separate.
Released ORB routes are MNQ → NQ and M2K → RTY. Released Order Flow routes are MNQ → NQ, MGC → GC, and MYM → YM. Unreleased White Rabbit research candidates are excluded from customer alerts and Red Pill software.
Disclosure standard
No source.
No number.
The frozen snapshot is calculated centrally from a source-hashed, reproducibly built research ledger, so customers do not have to load 30 days of Tick Replay. The rolling feed is generated only from allowlisted completed-trade records with explicit freshness. Missing history is labeled unavailable, not zero. Cross-instrument ticks are never added together; one-mini dollar equivalents are component illustrations, not synchronized portfolio P&L.
